SLC35A2 and prostate adenocarcinoma: Furthermore, the SLC35A2 promoter region was hypomethylated in testicular germ cell tumors (TGCT), BLCA, BRCA, esophageal carcinoma (ESCA), LIHC, prostate adenocarcinoma (PRAD), and stomach adenocarcinoma (STAD) (Supplementary Figure 1).